... 33,7 1A. 4 Nakao S, Takenaka T, Maeda M, Kodama C, Tanaka A, Tahara M, Yoshida A, Kuriyama M, Hayashibe H,Sakuraba H et al. (1995) An atypical variant of Fabry’sdisease in men with left ventricular ... 288–293.5 Nakao S, Kodama C, Takenaka T, Tanaka A, Yasum-oto Y, Yoshida A, Kanzaki T, Enriquez AL, Eng CM,Tanaka H et al. (2003) Fabry disease: detection of undi-agnosed hemodialysis patients and ... mice.ASSC therapy for Fabry disease inhumans The clinical proof -of- concept for ASSC therapy hasbeen investigated in cardiac Fabry disease by Frustaci and colleagues [48]. Galactose, a less...